Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of INCB053914 in Subjects With Advanced Malignancies

NCT02587598 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT02587598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02587598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of INCB053914 in Subjects With Advanced Malignancies
Lead sponsor
Incyte Corporation
Phase
Phase 1/2
Overall status
Terminated
Start date
December 29, 2015
Completion date
August 11, 2020
Enrollment
97 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors